Mucopolysaccharidosis type 9
MONDO:0011093An autosomal recessive lysosomal storage disease caused by mutation(s) in the HYAL1 gene, encoding hyaluronidase-1. It is characterized by short stature and hyaluronidase deficiency.
Also known as: MPS9, MPSIX, mucopolysaccharidosis type 9, mucopolysaccharidosis type IX, MPS 9, hyaluronidase deficiency, mucopolysaccharidosis IX, mucopolysaccharidosis, type 9
4 clinical trials for this condition and its sub-types, 1 tagged with Mucopolysaccharidosis type 9 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
MPS patients help design exercise program to boost mental health
Knowledge-focused Recruiting nowThis study aims to create a physical activity and sedentary behaviour program tailored for adults with mucopolysaccharidosis (MPS). Researchers will gather input from patients, doctors, nurses, and family members through interviews, focus groups, and workshops. The goal is to des…
Sponsor: Brunel University • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Massive french study aims to unlock secrets of rare MPS diseases
Knowledge-focused Recruiting nowThis observational study will follow up to 1,000 people in France with mucopolysaccharidosis (MPS), a group of rare genetic disorders. Researchers will collect medical data from patient records and ongoing checkups to map how the diseases progress and how current treatments affec…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC